1-7 of 7
Gil Fridberg
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Targeted, Low Cost Epigenetic Microarray for AML and MDS Detection

Miriam Neaman, Mika Bell, Jasline Deek, Rita Haldar, Amit Manor, Yakir Moshe, Irit Mazza Avivi, Moshe Mittelman, Roy Vitkon, Mor Levi, Roi Gat, Gil Fridberg, Natalia Birov, Guoda Daukėlaitė, Karolis Sablauskas, Andrejus Černovas, Andrius Zucenka, Vilmantė Vaitekėnaitė, Efstathios Kastritis, Tomas Papajik, Eva Kriegova, Martin Cernan, Tereza Dyskova, Yuval Ebenstein
Journal: Blood
Blood (2024) 144 (Supplement 1): 6142.
https://doi.org/10.1182/blood-2024-208540
Published: 2024
Journal Articles

Standardization Protocol to Mitigate Progression of Immune Effector Cell Associated Neurotoxicity Syndrome (ICANS) in Elderly Patients Treated with CD28 Co-Stimulatory Anti-CD19 CAR-T Cells - a Pilot Study

Gil Fridberg, Odelia Amit, Mohamad Ganayem, Felix Bukstein, Chava Perry, Irit Avivi Mazza, Ronit Gold, Ron Ram
Journal: Blood
Blood (2024) 144 (Supplement 1): 2086.
https://doi.org/10.1182/blood-2024-204837
Published: 2024
Journal Articles

Smoldering Multiple Myeloma Progressing to Active Multiple Myeloma Vs De-Novo Active Multiple Myeloma - a Comparison of Disease Characteristics, Organ Involvement and Outcomes in a Real-Life Multicenter Retrospective Cohort Study

Yael C. Cohen, Gil Fridberg, Inbar Cohen, Renana Robinson, Iuliana Vaxman, Tamir Shragai, Svetlana Trestman, Tomer Ziv-Baran, Natan Melamed, Pia Raanani, Irit Avivi Mazza
Journal: Blood
Blood (2023) 142 (Supplement 1): 4728.
https://doi.org/10.1182/blood-2023-186140
Published: 2023
Journal Articles

Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Active Primary Malignancy at HCT - a Bi-Institutional Retrospective Cohort Analysis

Ron Ram, Ido Wolf, Odelia Amit, Ronit Yerushalmi, Yakir Moshe, Noga Shem-Tov, Gil Fridberg, Ivetta Danylesko, Irit Avivi Mazza, Avichai Shimoni
Journal: Blood
Blood (2023) 142 (Supplement 1): 3590.
https://doi.org/10.1182/blood-2023-182826
Published: 2023
Journal Articles

Second Vs Third Line Treatment with Axicabtagene Ciloleucel for Large B Cell Lymphoma - a Real-Life National Multicenter Retrospective Cohort Study with Propensity Score Matching

Gil Fridberg, Odelia Amit, Liat Shargian, Ofrat Beyar Katz, Sigal Grisariu, Chava Perry, Ronit Gurion, Batia Avni, Tsila Zuckerman, Irit Avivi Mazza, Ron Ram
Journal: Blood
Blood (2023) 142 (Supplement 1): 4886.
https://doi.org/10.1182/blood-2023-188473
Published: 2023
Journal Articles

Outcomes of Acute Myeloid Leukemia Patients Suffering from an Additional Active Malignancy Treated with Venetoclax and Azacitidine: A Single Center Experience

Yakir Moshe, Shai Levi, Miriam Neaman, Roi Gat, Mor Levi, Nili Eilati, Gil Fridberg, Yotam Bornstein, Tamir Shragai, Tsipora Neuman, Roy Vitkon, Eliya Shachar, David Sarid, Ofer Merimsky, Moshe Mittelman, Irit Avivi Mazza
Journal: Blood
Blood (2023) 142 (Supplement 1): 5929.
https://doi.org/10.1182/blood-2023-186234
Published: 2023
Journal Articles

Impact of FDA-Approved Novel Agents for Steroid-Refractory Chronic Graft-Vs. Host Disease on Treatment Patterns and Outcomes - a Single Center Longitudinal Cohort Analysis

Gil Fridberg, Odelia Amit, Chen Karni, Dina Tshernichovsy, David Shasha, Vanessa Rouach, David Verssano, Amir Bar-Shai, Gilad Wasserman, Ilan Goldberg, Irit Avivi, Ron Ram
Journal: Blood
Blood (2022) 140 (Supplement 1): 10557–10558.
https://doi.org/10.1182/blood-2022-163786
Published: 2022